# Pay for supervised exercise the way we pay for drugs

Source: https://onco.cc/ideas/idea-bio2-exercise-reimbursement/  
OnCo record `idea-bio2-exercise-reimbursement` (Idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A large trial showed a structured exercise programme improved survival after bowel cancer. Almost no health system pays for it, so almost no patient gets it.

## Summary

A randomised trial of a three-year structured exercise programme after colon cancer chemotherapy reported improved disease-free survival, an effect size comparable with some adjuvant drugs at a small fraction of the cost. Reimbursement codes, referral pathways and trained providers are the barriers. Cardiac rehabilitation is the working template for how a supervised exercise service can be funded and audited at scale.

## Fields

- Kind: Idea
- Last checked: 2026-09-08
- Hypothesis: Introducing a reimbursed structured exercise benefit for curative-intent cancer patients achieves at least 40% uptake and is cost-saving within five years through reduced recurrence and hospital use.
- Rationale: Cardiac rehabilitation moved from trial evidence to funded service with measurable population benefit, and the delivery model transfers directly. Exercise also improves treatment tolerance, which supports dose intensity.
- Proposed test: A payer pilot in one region with a defined benefit and mandatory registry; measure uptake, adherence, treatment completion rates and total cost of care against matched controls.
- Maturity: early-clinical
- Actor: payer

## Sources

- Bottleneck evidence (Cachexia, toxicity and the limits of the patient): Fearon et al., Definition and classification of cancer cachexia (Lancet Oncology 2011): https://doi.org/10.1016/S1470-2045(10)70218-7

## Connected records

- ideas: [A dose-finding trial for exercise after cancer](https://onco.cc/ideas/idea-nl-exercise-dose-finding/), [Structured exercise prescribed like a drug in all curative-intent cancer care](https://onco.cc/ideas/idea-exercise-as-adjuvant/), [Write a rehabilitation prescription at the end of treatment, and fund it like a drug](https://onco.cc/ideas/idea-rejuv-rehabilitation-prescription-at-discharge/)
- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [Exercise & lifestyle oncology](https://onco.cc/technologies/exercise-oncology/), [Structured exercise programmes after curative treatment](https://onco.cc/technologies/structured-exercise-survivorship/), [The exercise prescription after cancer: the dose the guidelines state](https://onco.cc/technologies/exercise-prescription-after-cancer/)
- bottlenecks: [Cachexia, toxicity and the limits of the patient](https://onco.cc/bottlenecks/b-cachexia-supportive/), [Incentives reward me-too drugs and marginal gains](https://onco.cc/bottlenecks/b-incentive-misalignment/), [Rehabilitation is recommended everywhere and commissioned almost nowhere](https://onco.cc/bottlenecks/rejuv-agenda-rehabilitation-not-commissioned/), [Survivorship and late effects are neglected](https://onco.cc/bottlenecks/b-survivorship/)
- key papers: [CHALLENGE: a structured exercise programme after chemotherapy improves survival in colon cancer](https://onco.cc/key-papers/paper-challenge-exercise-nejm-2025/), [Definition and classification of cancer cachexia: an international consensus](https://onco.cc/key-papers/paper-fearon-lancet-oncol/)
- trials: [CHALLENGE (CCTG CO.21)](https://onco.cc/trials/challenge/)
- roadmaps: [Diet, exercise and lifestyle roadmap: causes established → interventions that disappointed → exercise proven as treatment](https://onco.cc/roadmaps/nutrition-lifestyle-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/idea-bio2-exercise-reimbursement.json